Global Life Science Instrumentation Market

Life Science Instrumentation Market Size, Share, Growth Analysis, By Technology(PCR, Spectroscopy, Microscopy, Chromatography), By Application(Clinical, Diagnostic, Research, Others), By Distribution Channel(Hospitals, Diagnostic Laboratories, Pharmaceutical, Biotechnology Companies), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2512 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 101 | Figures: 76

Life Science Instrumentation Market Insights

Life Science Instrumentation Market size was valued at USD 68.33 billion in 2019 and is poised to grow from USD 72.85 Billion in 2023 to USD 107.34 Billion by 2031, growing at a CAGR of 6.5% in the forecast period (2024-2031).

Life science instruments are utilized for quality testing of the products in manufacturing plants, analytical techniques and method validation during drug development, etc. Modern medicine is developed using a number of cutting-edge technologies. The demand for analytical instruments is expected to increase, the biotechnology and pharmaceutical sectors will expand, research and development activities will increase, number of laboratories worldwide will increase and hence, the market for life science equipment will expand.

In 2021, the ILAC MRA Signatories accredited about 85,000 laboratories, nearly 13,000 inspection bodies, over 600 proficiency testing providers, and 250 suppliers of reference materials. Increased focus on next generation sequencing (NGS) is estimated to support life science instrumentation market growth since sequencing technologies help in determining the cause of a disease. The market for life science instruments is estimated to gain from a rise in R&D in a number of industries, including biotechnology, pharmaceuticals, food and beverage, and agriculture. Additionally, it is estimated that the increased number of unique product releases by various well-known players will raise the growth of the life science instrumentation market during the forecast period. According to projections, there will be a rise in the demand for instruments used in life science as a result of increased testing due to the rising prevalence of chronic diseases in both developed and developing nations. Additionally, growing public-private investments in life science research and technological advancements in analytical equipment are driving the market growth.

Life science instrumentation market is estimated benefit from the rising demand for efficient diagnostic technologies and rising government funding for the creation of novel instruments used in the life sciences and medical device sectors. The expansion of the life science instrumentation market is estimated to be aided by the expanding uses of life science instruments in other industries, such as the food and beverage sector. In order to create novel pharmacological treatments and assess the quality of food, DNA is studied using the majority of life science and analytical technology. In this area, businesses are making significant investments in an effort to boost market expansion. The creation of new items will increase the precision with which samples may be diagnosed. It will help in focusing treatment on a particular patient.

US Life Science Instrumentation Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Life Science Instrumentation Market size was valued at USD 68.33 billion in 2019 and is poised to grow from USD 72.85 Billion in 2023 to USD 107.34 Billion by 2031, growing at a CAGR of 6.5% in the forecast period (2024-2031).

Key industry competitors in the life science instrumentation market are utilising market expansion tactics like acquisitions, mergers, and partnerships to broaden their product lines. Innovative technology and fresh product introductions have only been made by a select few companies. For example, NGS DreamPre, a fully automated method for next-generation sequencing (NGS), was introduced by Tecan Trading AG in February 2019. It produces quality-controlled, sequencing-ready NGS libraries in a matter of hours with no operator intervention or sample loss. The most popular business tactics utilised by market participants for expansion included product approval and launches, acquisition, collaborations, and agreements. For instance, due to its broad range of life science instrument products and associated accessories, Thermo Fisher Scientific, Inc. dominates the life science instrumentation market. Through insight-driven innovation and strategic M&A, Thermo Fisher has increased the scope of its product offering to better position itself in the market. For example, throughout the previous few years. In addition to the Vanquish Duo UHPLC system, Scientific Q Exactive UHMR mass spectrometer, Ion GeneStudio S5 Series next-generation sequencing systems, and ISQ EC Single Quadrupole mass spectrometer, Thermo Fisher also released the Biosystems QuantStudio 6 and 7 Pro Real-Time PCR Systems in April 2019 and the ISQ EC Single Quadrupole mass spectrometer in February 2018. 'Thermo Fisher Scientific Inc.', 'Agilent Technologies Inc.', 'Danaher Corporation', 'PerkinElmer Inc.', 'Waters Corporation', 'Bruker Corporation', 'Becton, Dickinson and Company', 'Bio-Rad Laboratories Inc.', 'Illumina Inc.', 'Qiagen N.V.', 'F. Hoffmann-La Roche Ltd.', 'GE Healthcare', 'Shimadzu Corporation', 'Oxford Instruments plc', 'Hitachi High-Technologies Corporation', 'JEOL Ltd.', 'Carl Zeiss AG', 'Nikon Corporation', 'Leica Microsystems GmbH', 'Olympus Corporation'

Increased Government’s initiatives.

Use of Artificial Intelligence to automate laboratories and development of similar high-tech instruments. For example, recently Agilent Technologies Inc. (NYSE: A) announced that it had purchased advanced artificial intelligence (AI) technology created by Virtual Control, a maker of AI and machine learning software that develops cutting-edge analysis solutions for lab testing. The software, dubbed ACIES, will be incorporated by Agilent into its top-tier gas chromatography and mass spectrometry (GS/MS) platforms in order to boost the effectiveness, efficiency, and precision of the high-throughput labs that the business works with all over the world.

North America is expected to continue dominating the life science instrumentation market during the projection period. The region has strong presence of food & beverage and pharmaceutical companies. Wherein, the product is used for testing of finished good for quality and safety testing. Thanks to the rising adoption of cutting-edge product introductions and technological developments, the region is enjoying higher market share. An important factor in the development of creative chemical methods in the area, which further propels the North American life science and chemical instruments market, has been the growing emphasis on the creation of new and enhanced drug assessment approaches to find highly complicated medications. For instance, Agilent unveiled the K6460S, a Class I medical device classified by the US Food and Drug Administration, in March 2020 as the next-generation clinical edition triple quadrupole LC/MS system. This technology is intended to enhance clinical lab workflows.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Life Science Instrumentation Market

Report ID: SQMIG35A2512

$5,300
BUY NOW GET FREE SAMPLE